Northeastern University

Sustained-release Talazoparib implants for localized treatment of BRCA1-deficient breast cancer

Belz J, Kumar R, Baldwin P, Noelle Castilla Ojo, Leal AS, Royce DB, Di Zhang D, van de Ven AL, Liby K, Srinivas Sridhar. “Sustained-release Talazoparib implants for localized treatment of BRCA1-deficient breast cancer”. Theranostics, 7(17): 4340-4349. PMCID: PMC5695017

Recent Publications

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia

Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade